Human Immunodeficiency Virus 1 conserved T-cell epitopes (HIV-1 conserved epitopes)

Human Immunodeficiency Virus 1 (HIV-1) conserved T-cell epitopes are specific sequences within the viral proteome that remain relatively invariant across different viral strains and clades due to high fitness costs associated with mutations in these regions (Hanke, 2019, Current Opinion in HIV and AIDS). These epitopes are typically located within internal viral proteins such as Gag, Pol, and Nef, and are presented by Major Histocompatibility Complex (MHC) molecules to trigger cellular immune responses (Mothe et al., 2015, Translational Medicine). In the context of drug and vaccine development, these epitopes serve as a therapeutic target designed to elicit broad and potent CD8+ cytotoxic T-lymphocyte (CTL) and CD4+ helper T-cell responses (Borthwick et al., 2014, PLOS ONE). By directing the immune system toward these vulnerable parts of the virus, researchers aim to prevent the rapid mutational escape that typically allows HIV-1 to evade host defenses. This strategy is central to the development of therapeutic vaccines intended to achieve a functional cure, where the host's immune system controls viral replication without the need for lifelong antiretroviral therapy (Rosás-Umbert et al., 2022, Frontiers in Immunology). Clinical candidates targeting these epitopes, such as the HTI immunogen and the HIVconsv series, have demonstrated the ability to shift the breadth and depth of T-cell responses in human trials (Mothe et al., 2019, Journal of Virology). Furthermore, these conserved targets are being explored in kick and kill strategies to eliminate the latent viral reservoir (Goonetilleke et al., 2013, Journal of Infectious Diseases). The ultimate goal is to induce an immune profile similar to that seen in elite controllers, individuals who naturally suppress HIV-1 replication.

Other names

HIV-1 conserved regionsHIV-1 T-cell immunogensConserved HIV-1 antigensHIV-1 T-cell epitopesHIV-1 conserved elements

Induction of broad, polyfunctional CD4+ and CD8+ T-cell responses against functionally constrained viral regions to prevent mutational escape and control viral replication.